Joris Silon

Joris is moving from his role as the country president of AstraZeneca US where he led and delivered significant growth for the company in its largest market. Joris brings extensive pharmaceutical experience, having joined the company in 2000 and has held leadership positions in Asia, Europe and the US.

“I am delighted that such a highly experienced and talented leader as Joris will lead our Investor Relations team through our next wave of growth. I would also like to thank Andy Barnett for his remarkable leadership of our Investor Relations team over the past 4 years and wish him the best of luck as he transitions to an important new role within the company,” says Aradhana Sarin, Chief Financial Officer.